Free Trial

Roivant Sciences (ROIV) SEC Filings & 10K Form

Roivant Sciences logo
$12.39 +0.46 (+3.86%)
Closing price 04:00 PM Eastern
Extended Trading
$12.36 -0.04 (-0.28%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Roivant Sciences SEC Filings

DateFilerForm TypeView
08/22/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
3:30 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025
4:32 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13G/A
08/11/2025
6:31 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2025
6:17 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
11:11 AM
FMR LLC (Filed by)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form SCHEDULE 13G/A
08/01/2025
8:09 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025
8:12 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Torti Frank (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
8:00 PM
Epperly Melissa B, (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
8:00 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
8:00 PM
Oren Ilan (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
6:32 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
8:01 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
8:01 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
10:35 AM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:35 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
3:38 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
4:49 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:33 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:42 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
4:14 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
6:53 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/29/2025
6:33 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
5:53 PM
Ramaswamy Vivek (Filed by)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form SCHEDULE 13G/A
05/15/2025
4:29 PM
Ramaswamy Vivek (Filed by)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:51 PM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
8:00 PM
Oren Ilan (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
GENIUS Act: Cancel Your Money? (Ad)

They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—not the government—have been handed control of a new class of programmable money. It’s not called a CBDC, but it acts just like one. Your spending could be tracked, limited, or even frozen—whether you opt in or not. Once this system becomes the default, escape won’t be easy.tc pixel

Get the free info kit with 3 ways to protect your money before control kicks in.
04/21/2025
8:00 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
8:00 PM
Epperly Melissa B, (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
2:22 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/21/2025
6:42 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
6:54 AM
Immunovant, Inc. (Subject)
Roivant Sciences (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SCHEDULE 13D/A
04/01/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:21 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:01 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:01 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:01 PM
Humes Jennifer (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:27 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:30 PM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
6:51 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:11 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:00 PM
Humes Jennifer (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2025
6:19 AM
Arbutus Biopharma Corp (Subject)
Roivant Sciences (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SCHEDULE 13D/A
02/24/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
8:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:45 PM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
2:35 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
8:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
11:15 AM
Kumar Rakhi (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144/A
02/14/2025
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
1:00 PM
QVT Financial LP (Filed by)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:59 AM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
SB INVESTMENT ADVISERS LTD (0001731509) (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:14 PM
Kumar Rakhi (Reporting)
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
4:29 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:16 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2025
6:15 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
8:00 PM
Oren Ilan (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
8:00 PM
MOMTAZEE JAMES C (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
8:00 PM
Epperly Melissa B, (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
10:40 AM
Ramaswamy Vivek (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:04 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:04 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:04 PM
Kumar Rakhi (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:30 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:36 PM
Immunovant, Inc. (Issuer)
Roivant Sciences (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:30 PM
Immunovant, Inc. (Subject)
Roivant Sciences (Filed by)
Roivant Sciences Ltd. (Filed by)
Form SCHEDULE 13D/A
12/31/2024
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:54 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Venker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 PM
Kumar Rakhi (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Sukhatme Mayukh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:14 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Sukhatme Mayukh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
GENIUS Act: Cancel Your Money? (Ad)

They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—not the government—have been handed control of a new class of programmable money. It’s not called a CBDC, but it acts just like one. Your spending could be tracked, limited, or even frozen—whether you opt in or not. Once this system becomes the default, escape won’t be easy.tc pixel

Get the free info kit with 3 ways to protect your money before control kicks in.
12/26/2024
7:02 AM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Sukhatme Mayukh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:21 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Sukhatme Mayukh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Sukhatme Mayukh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:29 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Venker Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:33 PM
Roivant Sciences (Subject)
Roivant Sciences Ltd. (Subject)
Sukhatme Mayukh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
8:00 PM
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Sukhatme Mayukh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:20 AM
Roivant Sciences (Filer)
Roivant Sciences Ltd. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
8:00 PM
Pulik Richard (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:00 PM
Gline Matthew (Reporting)
Roivant Sciences (Issuer)
Roivant Sciences Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ROIV) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners